Veranstaltungsprogramm

Diabetes and cardiovascular disease.

Nikolaus Marx

Universitätsklinikum Aachen - RWTH Aachen, Aachen, Deutschland

Targeting Early Innate Immune Cell Activation to Protect the Brain After Stroke

Vikramjeet Singh^1,2

1: Institute for Experimental Immunology and Imaging, University of Duisburg-Essen, Esse, Germany; 2: University Hospital Essen, University of Duisburg-Essen, Essen, Germany,

The aryl hydrocarbon receptor (AhR) is a novel regulator of lipid metabolism and atherosclerosis development.

Rosanna Huchzermeier¹, Renske de Jong¹, Vasiliki Triantafyllidou², Donato Santovito², Emiel van der Vorst^1,2

1: Universitatsklinikum Aachen, Aachen, Deutschland; 2: IPEK, LMU München, Deutschland

Ezh2 shapes T cell plasticity to drive atherosclerosis

Cecilia Bonfiglio

IPEK, LMU Klinikum, München, Deutschland

Translational therapeutic value of heterogenuous inflammatory acitvity in AAA

Albert Busch

Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Deutschland

Exploration and modulation of innate immune responses in syndromic and non-syndromic aortopathy

Hafid Ait-Oufella

Universités-Praticien Hospitalier, Paris, Frankreich

Nitrated fatty acids as a promising pharmacological treatment for abdominal aortic aneurysm

Per Arkenberg¹, Marta Stei², Theresa Uebing³, Agnesa Mazrekaj³, Leon Moll¹, Hannah Seelhorst¹, Philipp Barnowski¹, Gerhard Sengle¹, Valerie Lohner¹, Verena Hoerr², Albert Busch⁴, Holger Winkels¹, Tom Riffelmacher¹, Malte Kelm³, Georg Nickenig², Stephan Baldus¹, Markus U. Wagenhäuser³, Martin Mollenhauer¹

1: Universitätsklinik Köln, Köln, Deutschland; 2: Universität Bonn, Bonn, Deutschland; 3: Universität Düsseldorf, Düsseldorf, Deutschland; 4: Technische Universität Dresden, Dresden, Deutschland

PI3 kinase-α-deficiency in vascular smooth muscle cells increases atherosclerosis and plaque instability.

Mario Zierden, Eva Maria Berghausen, Leoni Gnatzy-Feik, Lea Zimmermann, Stephan Baldus, Marius Vantler, Stephan Roenkranz

Uniklinik Köln, Köln, Deutschland